Differential functional patterns of memory CD4+ and CD8+ T-cells from volunteers immunized with Ty21a typhoid vaccine observed using a recombinant Escherichia coli system expressing S. Typhi proteins.
暂无分享,去创建一个
H. Tettelin | A. D. De Groot | M. Sztein | W. Martin | R. Salerno-Gonçalves | David Luo | Qin Guo | M. Ardito | Anne Searls De Groot
[1] M. Levine,et al. Crosstalk between leukocytes triggers differential immune responses against Salmonella enterica serovars Typhi and Paratyphi , 2019, PLoS neglected tropical diseases.
[2] M. Sztein,et al. Association between S. Typhi-specific memory CD4+ and CD8+ T responses in the terminal ileum mucosa and in peripheral blood elicited by the live oral typhoid vaccine Ty21a in humans , 2019, Human vaccines & immunotherapeutics.
[3] M. Levine,et al. Manipulation of Salmonella Typhi Gene Expression Impacts Innate Cell Responses in the Human Intestinal Mucosa , 2018, Front. Immunol..
[4] M. Sztein. Is a Human CD8 T-Cell Vaccine Possible, and if So, What Would It Take? CD8 T-Cell-Mediated Protective Immunity and Vaccination against Enteric Bacteria. , 2018, Cold Spring Harbor perspectives in biology.
[5] G. Dougan,et al. Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses , 2018, Nature Immunology.
[6] William A. Flavahan,et al. Salmonella Typhi Colonization Provokes Extensive Transcriptional Changes Aimed at Evading Host Mucosal Immune Defense During Early Infection of Human Intestinal Tissue , 2018, EBioMedicine.
[7] Liping Lin,et al. Reciprocal Regulation of OmpR and Hfq and Their Regulatory Actions on the Vi Polysaccharide Capsular Antigen in Salmonella enterica Serovar Typhi , 2018, Current Microbiology.
[8] H. Tettelin,et al. Use of a novel antigen expressing system to study the Salmonella enterica serovar Typhi protein recognition by T cells , 2017, PLoS neglected tropical diseases.
[9] A. Westermann,et al. RNA target profiles direct the discovery of virulence functions for the cold-shock proteins CspC and CspE , 2017, Proceedings of the National Academy of Sciences.
[10] A. Cunningham,et al. Salmonella Typhi Porins OmpC and OmpF Are Potent Adjuvants for T-Dependent and T-Independent Antigens , 2017, Front. Immunol..
[11] L. Magder,et al. Importance of Salmonella Typhi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge Model , 2017, Front. Immunol..
[12] J. Galen,et al. Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity , 2016, EcoSal Plus.
[13] Ross N. W. Kettleborough,et al. Alternative haplotypes of antigen processing genes in zebrafish diverged early in vertebrate evolution , 2016, Proceedings of the National Academy of Sciences.
[14] L. Magder,et al. Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans , 2016, Journal of Translational Medicine.
[15] Leonard Moise,et al. iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines , 2015, Human vaccines & immunotherapeutics.
[16] D. Bumann. Identification of Protective Antigens for Vaccination against Systemic Salmonellosis , 2014, Front. Immunol..
[17] M. Joshi,et al. Peptide Vaccine: Progress and Challenges , 2014, Vaccines.
[18] S. Czinn,et al. Characterization and Functional Properties of Gastric Tissue-Resident Memory T Cells from Children, Adults, and the Elderly , 2014, Front. Immunol..
[19] M. Sztein,et al. B Cells Modulate Mucosal Associated Invariant T Cell Immune Responses , 2014, Front. Immunol..
[20] C. Perez-Shibayama,et al. Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties , 2013, Immunology.
[21] J. Galán,et al. Conferring Virulence: Structure and Function of the chimeric A2B5 Typhoid Toxin , 2013, Nature.
[22] C. Fraser,et al. Impact of Oral Typhoid Vaccination on the Human Gut Microbiota and Correlations with S. Typhi-Specific Immunological Responses , 2013, PloS one.
[23] P. Muranski,et al. Essentials of Th17 cell commitment and plasticity. , 2013, Blood.
[24] A. Falanga,et al. Microbe-Host Interactions: Structure and Role of Gram-Negative Bacterial Porins , 2012, Current protein & peptide science.
[25] D. Bumann,et al. Immunity to Intracellular Salmonella Depends on Surface-associated Antigens , 2012, PLoS pathogens.
[26] M. Sztein,et al. Heterogeneity of Multifunctional IL-17A Producing S. Typhi-Specific CD8+ T Cells in Volunteers following Ty21a Typhoid Immunization , 2012, PloS one.
[27] R. Danner,et al. Th17 cells are long lived and retain a stem cell-like molecular signature. , 2011, Immunity.
[28] A. Fasano,et al. Engineering of a multicellular organotypic model of the human intestinal mucosa. , 2011, Gastroenterology.
[29] M. Arifuzzaman,et al. Interferon-γ and Proliferation Responses to Salmonella enterica Serotype Typhi Proteins in Patients with S. Typhi Bacteremia in Dhaka, Bangladesh , 2011, PLoS neglected tropical diseases.
[30] S. Porwollik,et al. Analysis of Salmonella enterica Serotype Paratyphi A Gene Expression in the Blood of Bacteremic Patients in Bangladesh , 2010, PLoS neglected tropical diseases.
[31] M. Sztein,et al. Ex Vivo Kinetics of Early and Long-Term Multifunctional Human Leukocyte Antigen E-Specific CD8+ Cells in Volunteers Immunized with the Ty21a Typhoid Vaccine , 2010, Clinical and Vaccine Immunology.
[32] D. Littman,et al. Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.
[33] D. Ott,et al. CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that exosomes contain CD45: no evidence for a distinct exosome/HIV-1 budding pathway , 2008, Retrovirology.
[34] M. Levine,et al. Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans , 2008, Mucosal Immunology.
[35] D. Frishman,et al. Protein abundance profiling of the Escherichia coli cytosol , 2008, BMC Genomics.
[36] S. Winter,et al. The Salmonella enterica serotype Typhi regulator TviA reduces interleukin‐8 production in intestinal epithelial cells by repressing flagellin secretion , 2007, Cellular microbiology.
[37] M. Sztein. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] G. Dougan,et al. The genome of Salmonella enterica serovar Typhi. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] R. Misra,et al. Low molecular weight proteins of outer membrane of Salmonella typhimurium are immunogenic in Salmonella induced reactive arthritis revealed by proteomics , 2007, Clinical and experimental immunology.
[40] M. Levine,et al. Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909. , 2007, Vaccine.
[41] M. Sztein,et al. Cell-mediated immunity and the challenges for vaccine development. , 2006, Trends in microbiology.
[42] R. Koup,et al. Intracellular cytokine optimization and standard operating procedure , 2006, Nature Protocols.
[43] Nathan D. Berkowitz,et al. Directed antigen delivery as a vaccine strategy for an intracellular bacterial pathogen. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[44] Ying Wang,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.
[45] R. D. Hatton,et al. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.
[46] J. O’Neill,et al. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations. , 2005, The Journal of infectious diseases.
[47] M. Sztein,et al. Immunization of Volunteers with Salmonella enterica Serovar Typhi Strain Ty21a Elicits the Oligoclonal Expansion of CD8+ T Cells with Predominant Vβ Repertoires , 2005, Infection and Immunity.
[48] M. Fernandez-Vina,et al. Identification of a Human HLA-E-Restricted CD8+ T Cell Subset in Volunteers Immunized with Salmonella enterica Serovar Typhi Strain Ty21a Typhoid Vaccine1 , 2004, The Journal of Immunology.
[49] J. Puente,et al. OmpR and LeuO Positively Regulate the Salmonella enterica Serovar Typhi ompS2 Porin Gene , 2004, Journal of bacteriology.
[50] Antonio Lanzavecchia,et al. Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.
[51] Simon C Watkins,et al. Escherichia coli Expressing Recombinant Antigen and Listeriolysin O Stimulate Class I-Restricted CD8+ T Cells following Uptake by Human APC1 , 2004, The Journal of Immunology.
[52] R. Koup,et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.
[53] M. Andreeff,et al. Selection of chronic lymphocytic leukemia binding peptides. , 2003, Cancer research.
[54] F. Blattner,et al. Comparative Genomics of Salmonellaenterica Serovar Typhi Strains Ty2 and CT18 , 2003, Journal of bacteriology.
[55] M. Levine,et al. Concomitant Induction of CD4+ and CD8+ T Cell Responses in Volunteers Immunized with Salmonella enterica Serovar Typhi Strain CVD 908-htrA 1 , 2003, The Journal of Immunology.
[56] A. Svennerholm,et al. Oral Immunization with a Salmonella enterica Serovar Typhi Vaccine Induces Specific Circulating Mucosa-Homing CD4+ and CD8+ T Cells in Humans , 2002, Infection and Immunity.
[57] M. Sztein,et al. Characterization of CD8+ Effector T Cell Responses in Volunteers Immunized with Salmonella enterica Serovar Typhi Strain Ty21a Typhoid Vaccine1 , 2002, The Journal of Immunology.
[58] M. Levine,et al. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. , 1999, Vaccine.
[59] D. Favre,et al. Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria , 1999, Infection and Immunity.
[60] M. Inouye,et al. The CspA family in Escherichia coli : multiple gene duplication for stress adaptation , 1998, Molecular microbiology.
[61] M. Levine,et al. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. , 1995, Journal of immunology.
[62] G. Dougan,et al. Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression , 1994, Infection and immunity.
[63] P. Mastroeni,et al. Role of T cells, TNFα and IFNγ in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro− salmonella vaccines , 1992 .
[64] R. Black,et al. LARGE-SCALE FIELD TRIAL OF TY21A LIVE ORAL TYPHOID VACCINE IN ENTERIC-COATED CAPSULE FORMULATION , 1987, The Lancet.
[65] A. D. De Groot,et al. Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases , 2014, Expert review of vaccines.